EV-0300 series (Evolva Biotech)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEV-0300 series (Evolva Biotech)
Drug Alias NameRAR agonists (Evolva Biotech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors agonists
TargetsRetinoic acid receptors
Therapy Area/IndicationsObesitySkin DiseasesRespiratory Tract Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvolva Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvolva Sa
Active IndicationsN/A
Inactive IndicationsObesitySkin DiseasesRespiratory Tract Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A